Drugs / BIBN 4096
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02194348 | Feb → Mar 2000 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBN 4096 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02194348 ↗ |
| Route | Subcutaneous | “BIBN 4096 BS after single subcutaneous administration” NCT02194348 ↗ |